CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 29 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,721,299 | $10,672,000 | 1.91% |
| ARS Investment Partners, LLC | 785,343 | $4,869,000 | 0.63% |
| PERKINS CAPITAL MANAGEMENT INC | 35,500 | $220,000 | 0.23% |
| Benchmark Capital Advisors | 32,900 | $204,000 | 0.16% |
| FNY Managed Accounts LLC | 2,784 | $17,000 | 0.02% |
| THOMPSON DAVIS & CO., INC. | 1,500 | $9,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80,100 | $497,000 | 0.01% |
| WELLINGTON MANAGEMENT GROUP LLP | 918,535 | $5,695,000 | 0.00% |
| ROYCE & ASSOCIATES LP | 21,900 | $136,000 | 0.00% |
| Phocas Financial Corp. | 20,000 | $0 | 0.00% |